Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Fieschi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the Neurological Sciences|February 5, 2004
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trialValentina Tomassini, Carlo Pozzilli, Emanuela Onesti, et al.
Experimental Brain Research|May 3, 2005
Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditionsManuela De Michele, Omar Touzani, Alan C Foster, et al.
Stroke|August 22, 2009
Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) studyCarlos S Kase, Gregory W Albers, Christopher Bladin, et al.
Lancet (London, England)|April 24, 2007
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonDavid G Sherman, Gregory W Albers, Christopher Bladin, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 29, 2006
Distribution of potential cardiac sources of embolism in young and older stroke patients: implications for recurrent vascular eventsStefano De Castro, Maurizia Rasura, Emanuele Di Angelantonio, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 31, 2002
Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trialJulien Bogousslavsky, Stephen J Victor, Eliseo O Salinas, et al.
Lancet (London, England)|March 16, 2004
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsWerner Hacke, Geoffrey Donnan, Cesare Fieschi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the Neurological Sciences|February 5, 2004
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trialValentina Tomassini, Carlo Pozzilli, Emanuela Onesti, et al.
Experimental Brain Research|May 3, 2005
Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditionsManuela De Michele, Omar Touzani, Alan C Foster, et al.
Stroke|August 22, 2009
Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) studyCarlos S Kase, Gregory W Albers, Christopher Bladin, et al.
Lancet (London, England)|April 24, 2007
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonDavid G Sherman, Gregory W Albers, Christopher Bladin, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 29, 2006
Distribution of potential cardiac sources of embolism in young and older stroke patients: implications for recurrent vascular eventsStefano De Castro, Maurizia Rasura, Emanuele Di Angelantonio, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 31, 2002
Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trialJulien Bogousslavsky, Stephen J Victor, Eliseo O Salinas, et al.
Lancet (London, England)|March 16, 2004
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsWerner Hacke, Geoffrey Donnan, Cesare Fieschi, et al.
Pageof 1